- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting IGF-1 signaling pathways in gynecologic malignancies
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume 17, Issue 3, Pages 307-320
Publisher
Informa Healthcare
Online
2013-01-09
DOI
10.1517/14728222.2013.749863
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting the Insulin-like Growth Factor Axis for the Development of Novel Therapeutics in Oncology
- (2012) J. Gao et al. CANCER RESEARCH
- Insulin-like growth factor type 1 receptor (IGF-1R) exclusive nuclear staining: A predictive biomarker for IGF-1R monoclonal antibody (Ab) therapy in sarcomas
- (2012) Irène Asmane et al. EUROPEAN JOURNAL OF CANCER
- BRCA1 is Expressed in Uterine Serous Carcinoma (USC) and Controls Insulin-Like Growth Factor I Receptor (IGF-IR) Gene Expression in USC Cell Lines
- (2012) Keren Amichay et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- OCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
- (2012) Carol Aghajanian et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting the Insulin Growth Factor and the Vascular Endothelial Growth Factor Pathways in Ovarian Cancer
- (2012) M. Shao et al. MOLECULAR CANCER THERAPEUTICS
- Heterodimerization of Glycosylated Insulin-Like Growth Factor-1 Receptors and Insulin Receptors in Cancer Cells Sensitive to Anti-IGF1R Antibody
- (2012) Jun Gyu Kim et al. PLoS One
- Insulin-Like Growth Factors Promote Vasculogenesis in Embryonic Stem Cells
- (2012) Stephanie M. Piecewicz et al. PLoS One
- Ovarian cancer: Stat3, RhoA and IGF-IR as therapeutic targets
- (2011) Caroline Gest et al. CANCER LETTERS
- Dual IGF-I/II-Neutralizing Antibody MEDI-573 Potently Inhibits IGF Signaling and Tumor Growth
- (2011) J. Gao et al. CANCER RESEARCH
- Insulin-like growth factor-I receptor (IGF-IR) targeting with monoclonal antibody cixutumumab (IMC-A12) inhibits IGF-I action in endometrial cancer cells
- (2011) Zohar Attias-Geva et al. EUROPEAN JOURNAL OF CANCER
- p53 Regulates insulin-like growth factor-I receptor gene expression in uterine serous carcinoma and predicts responsiveness to an insulin-like growth factor-I receptor-directed targeted therapy
- (2011) Zohar Attias-Geva et al. EUROPEAN JOURNAL OF CANCER
- Insulin-like growth factor-I receptor inhibition by specific tyrosine kinase inhibitor NVP-AEW541 in endometrioid and serous papillary endometrial cancer cell lines
- (2011) Zohar Attias-Geva et al. GYNECOLOGIC ONCOLOGY
- The insulin-like growth factor 1 pathway is a potential therapeutic target for low-grade serous ovarian carcinoma
- (2011) Erin R. King et al. GYNECOLOGIC ONCOLOGY
- Genetic variation in insulin-like growth factor 2 may play a role in ovarian cancer risk
- (2011) Celeste Leigh Pearce et al. HUMAN MOLECULAR GENETICS
- Increase in Docetaxel-Resistance of Ovarian Carcinoma-Derived RMG-1 Cells with Enhanced Expression of Lewis Y Antigen
- (2011) Fan Zhang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Down-regulation of IGF-1R expression inhibits growth and enhances chemosensitivity of endometrial carcinoma in vitro
- (2011) Shanrong Shu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- A Phase 3 Trial of Bevacizumab in Ovarian Cancer
- (2011) Timothy J. Perren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Insulin-like Growth Factor: Current Concepts and New Developments in Cancer Therapy
- (2011) Erin R. King et al. Recent Patents on Anti-Cancer Drug Discovery
- AMG 479, a Novel IGF-1-R Antibody, Inhibits Endometrial Cancer Cell Proliferation Through Disruption of the PI3K/Akt and MAPK Pathways
- (2011) Albert Mendivil et al. Reproductive Sciences
- The insulin-like growth factor-I receptor as an oncogene
- (2011) Haim Werner et al. ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY
- Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab
- (2010) A Gualberto et al. BRITISH JOURNAL OF CANCER
- The insulin-like growth factor-I receptor inhibitor figitumumab (CP-751,871) in combination with docetaxel in patients with advanced solid tumours: results of a phase Ib dose-escalation, open-label study
- (2010) L R Molife et al. BRITISH JOURNAL OF CANCER
- Insulin-like Growth Factor 2 Expression Modulates Taxol Resistance and Is a Candidate Biomarker for Reduced Disease-Free Survival in Ovarian Cancer
- (2010) G. S. Huang et al. CLINICAL CANCER RESEARCH
- Targeting insulin-like growth factor 1 receptor in sarcomas
- (2010) Katia Scotlandi et al. CURRENT OPINION IN ONCOLOGY
- Insufficient evaluation of adverse events is not a proof of safety
- (2010) L. G. Hemkens et al. DIABETOLOGIA
- Common genetic variation within IGFI, IGFII, IGFBP-1, and IGFBP-3 and endometrial cancer risk
- (2010) Monica McGrath et al. GYNECOLOGIC ONCOLOGY
- Cervical Scrapes Levels of Insulin-like Growth Factor-II and Insulin-like Growth Factor Binding Protein 3 in Women with Squamous Intraepithelial Lesions and Cervical Cancer
- (2010) M.-L. Serrano et al. HORMONE AND METABOLIC RESEARCH
- Inhibitory effect of siRNA targeting IGF-1R on endometrial carcinoma
- (2010) Shanrong Shu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Interactions between IGF-I, estrogen receptor- (ER ), and ER in regulating growth/apoptosis of MCF-7 human breast cancer cells
- (2010) R. A. Mendoza et al. JOURNAL OF ENDOCRINOLOGY
- Plasma levels of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in women with cervical neoplasia
- (2010) Si Won Lee et al. Journal of Gynecologic Oncology
- Cancer Statistics, 2009
- (2009) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Hyperactivation of the Insulin-like Growth Factor Receptor I Signaling Pathway Is an Essential Event for Cisplatin Resistance of Ovarian Cancer Cells
- (2009) N. Eckstein et al. CANCER RESEARCH
- Common genetic variation in IGF1 , IGFBP1 and IGFBP3 and ovarian cancer risk
- (2009) Kathryn L. Terry et al. CARCINOGENESIS
- Clinical Development of Inhibitors of the Insulin-like Growth Factor Receptor in Oncology
- (2009) Antonio Gualberto et al. CURRENT DRUG TARGETS
- Insulin glargine use and short-term incidence of malignancies—a population-based follow-up study in Sweden
- (2009) J. M. Jonasson et al. DIABETOLOGIA
- Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group
- (2009) H. M. Colhoun et al. DIABETOLOGIA
- Targeting the IGF1 axis in cancer proliferation
- (2009) Ilan Bruchim et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- BMS-536924 sensitizes human epithelial ovarian cancer cells to the PARP inhibitor, 3-aminobenzamide
- (2009) Marie-Claude Beauchamp et al. GYNECOLOGIC ONCOLOGY
- AMG 479, a fully human anti-insulin-like growth factor receptor type I monoclonal antibody, inhibits the growth and survival of pancreatic carcinoma cells
- (2009) P. J. Beltran et al. MOLECULAR CANCER THERAPEUTICS
- Emerging role of insulin-like growth factor receptor inhibitors in oncology: early clinical trial results and future directions
- (2009) A Gualberto et al. ONCOGENE
- Clinical implications of insulin-like growth factor 1 system in early-stage cervical cancer
- (2008) Y-F Huang et al. BRITISH JOURNAL OF CANCER
- Insulin-Like Growth Factor Axis and Oncogenic Human Papillomavirus Natural History
- (2008) T. G. Harris et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- A Prospective Evaluation of Insulin and Insulin-like Growth Factor-I as Risk Factors for Endometrial Cancer
- (2008) M. J. Gunter et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- The Type 1 Insulin-Like Growth Factor Receptor Pathway
- (2008) M. M. Chitnis et al. CLINICAL CANCER RESEARCH
- The insulin receptor substrate-1: A biomarker for cancer?
- (2008) Renato Baserga EXPERIMENTAL CELL RESEARCH
- Targeting the type 1 insulin-like growth factor receptor as a treatment for cancer
- (2008) John SP Yuen et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Serum insulin-like growth factor (IGF)-I, IGF binding protein (IGFBP)-3, leptin concentrations and insulin resistance in benign and malignant epithelial ovarian tumors in postmenopausal women
- (2008) Ibrahim Serdar Serin et al. GYNECOLOGICAL ENDOCRINOLOGY
- Differential Expression of IGF-I and Insulin Receptor Isoforms in HPV Positive and Negative Human Cervical Cancer Cell Lines
- (2008) M.-L. Serrano et al. HORMONE AND METABOLIC RESEARCH
- Gene Expression Changes in Cervical Squamous Cell Carcinoma After Initiation of Chemoradiation and Correlation With Clinical Outcome
- (2008) Ann H. Klopp et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- IGF and Insulin Receptor Signaling in Breast Cancer
- (2008) Antonino Belfiore et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- IGF-1 Receptor Inhibitors in Clinical Trials—Early Lessons
- (2008) S. John Weroha et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- The metabolic syndrome, IGF-1, and insulin action
- (2008) Yasumichi Arai et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Similarities and differences between insulin and IGF-I: Structures, receptors, and signalling pathways
- (2008) Haim Werner et al. ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search